SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001040188-18-000052
Filing Date
2018-02-08
Accepted
2018-02-08 16:04:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 immunedesign13ga2_123117.htm SC 13G/A 42056
  Complete submission text file 0001040188-18-000052.txt   43717
Mailing Address 4900 TIEDEMAN RD BROOKLYN OH 44144
Business Address 4900 TIEDEMAN RD BROOKLYN OH 44144 2168982400
VICTORY CAPITAL MANAGEMENT INC (Filed by) CIK: 0001040188 (see all company filings)

IRS No.: 132700161 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88256 | Film No.: 18585757
SIC: 2834 Pharmaceutical Preparations